Search Results - "Greening, Andrew P"

A Randomized Controlled Trial of Nebulized Gentamicin in Non―Cystic Fibrosis Bronchiectasis by MURRAY, Maeve P, GOVAN, John R. W, DOHERTY, Catherine J, SIMPSON, A. John, WILKINSON, Thomas S, CHALMERS, James D, GREENING, Andrew P, HASLETT, Christopher, HILL, Adam T

“…Bronchiectasis is a chronic debilitating disease with few evidence-based long-term treatments. A randomized controlled trial assessing the efficacy of…”
Get full text

Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases by Gray, Robert D, MacGregor, Gordon, Noble, Donald, Imrie, Margaret, Dewar, Maria, Boyd, A. Christopher, Innes, J. Alastair, Porteous, David J, Greening, Andrew P

“…Markers of inflammatory activity are important for assessment and management of many respiratory diseases. Markers that are currently unrecognized may be more…”
Get full text

Sputum trace metals are biomarkers of inflammatory and suppurative lung disease by Gray, Robert D, Duncan, Andrew, Noble, Donald, Imrie, Margaret, O'Reilly, Dennis St J, Innes, J Alastair, Porteous, David J, Greening, Andrew P, Boyd, A Christopher

“…Induced sputum cytology and protein biomarkers can be used to assess airways inflammation. Increases in sputum iron have been described in inflammatory lung…”
Get more information

Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis by Mecklenburgh, Katy I., Walmsley, Sarah R., Cowburn, Andrew S., Wiesener, Michael, Reed, Benjamin J., Upton, Paul D., Deighton, John, Greening, Andrew P., Chilvers, Edwin R.

“…Neutrophil apoptosis represents a major mechanism involved in the resolution of acute inflammation. In contrast to the effect of hypoxia observed in many other…”
Get full text

Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis by Reid, Philip A, McAllister, David A, Boyd, A Christopher, Innes, J Alastair, Porteous, David, Greening, Andrew P, Gray, Robert D

Get full text

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation by Horsley, Alex R, Davies, Jane C, Gray, Robert D, Macleod, Kenneth A, Donovan, Jackie, Aziz, Zelena A, Bell, Nicholas J, Rainer, Margaret, Mt-Isa, Shahrul, Voase, Nia, Dewar, Maria H, Saunders, Clare, Gibson, James S, Parra-Leiton, Javier, Larsen, Mia D, Jeswiet, Sarah, Soussi, Samia, Bakar, Yusura, Meister, Mark G, Tyler, Philippa, Doherty, Ann, Hansell, David M, Ashby, Deborah, Hyde, Stephen C, Gill, Deborah R, Greening, Andrew P, Porteous, David J, Innes, J Alastair, Boyd, A Christopher, Griesenbach, Uta, Cunningham, Steve, Alton, Eric W F W

“…Clinical trials in cystic fibrosis (CF) have been hindered by the paucity of well characterised and clinically relevant outcome measures. To evaluate a range…”
Get more information

Atopy influences exhaled nitric oxide levels in adult asthmatics by Ho, L P, Wood, F T, Robson, A, Innes, J A, Greening, A P

“…To examine whether atopy influences exhaled nitric oxide (NO) levels in adults with established asthma. Specialist respiratory unit in a university teaching…”
Get more information

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal by Chapman, Kenneth R, Barnes, Neil C, Greening, Andrew P, Jones, Paul W, Pedersen, S

“…The use of a combination inhaler containing budesonide and formoterol as both maintenance and quick relief therapy (SMART) has been recommended as an improved…”
Get more information

Reduced interleukin-18 levels in BAL specimens from patients with asthma compared to patients with sarcoidosis and healthy control subjects by Ho, Ling-Pei, Davis, Margaret, Denison, Alan, Wood, Fraser T, Greening, Andrew P

“…To investigate whether differing airway interleukin (IL)-18 levels may be implicated in the pathogenesis of asthma and sarcoidosis. University teaching…”
Get more information

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial by BJERMER, Leif, BISGAARD, Hans, LEFF, Jonadian A, POLOS, Peter G, BOUSQUET, Jean, FABBRI, Leonardo M, GREENING, Andrew P, HAAHTELA, Tari, HOLGATE, Stephen T, PICADO, Cesar, MENTEN, Joris, BALACHAMDRA DASS, S

“…OBJECTIVES: To assess the effect of montelukast versus salmeterol added to inhaled fluticasone propionate on asthma exacerbation in patients whose symptoms are…”
Get full text

The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis by DiSantostefano, Rachael L, Boudiaf, Nada, Stempel, David A, Barnes, Neil C, Greening, Andrew P

“…Inhaled corticosteroid/long-acting β 2 -agonist (ICS/LABA) fixed-dose combinations are recommended regular maintenance options for asthma. ICS/LABAs containing…”
Get full text

Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis by Horsley, Alex R, Macleod, Kenneth A, Robson, Andrew G, Lenney, Jill, Bell, Nicholas J, Cunningham, Steve, Greening, Andrew P, Gustafsson, Per M, Innes, J. Alastair

“…Abstract Scond and Sacin are derived from analysis of concentration-normalized phase III slopes (SnIII ) of a multiple breath inert gas washout. Studies in…”
Get full text

Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid by MacGregor, Gordon, Gray, Robert D, Hilliard, Thomas N, Imrie, Margaret, Boyd, A. Christopher, Alton, Eric W.F.W, Bush, Andrew, Davies, Jane C, Innes, J. Alastair, Porteous, David J, Greening, Andrew P

“…Abstract Background For cystic fibrosis (CF) patients there is a lack of good assays of disease activity and response to new therapeutic interventions,…”
Get full text

Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma by Bradshaw, Tracey A, Matusiewicz, Simon P, Crompton, Graham K, Alastair Innes, J, Greening, Andrew P

“…Summary Background Treatment of acute asthma is based on rapid reversal of bronchospasm and airway inflammation. Magnesium sulphate (MgSO4 ) is known to have a…”
Get full text

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial by Bjermer, Leif, Bisgaard, Hans, Bousquet, Jean, Fabbri, Leonardo M, Greening, Andrew P, Haahtela, Tari, Holgate, Stephen T, Picado, Cesar, Menten, Joris, Balachandra Dass, S, Leff, Jonathan A, Polos, Peter G

“…Abstract Objectives To assess the effect of montelukast versus salmeterol added to inhaled fluticasone propionate on asthma exacerbation in patients whose…”
Get full text

Human Cytokines: Their Role in Disease and Therapy by Greening, Andrew P, Puri, Raj K

Get full text

Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma by Rossi, A G, Haslett, C, Hirani, N, Greening, A P, Rahman, I, Metz, C N, Bucala, R, Donnelly, S C

“…Macrophage migration inhibitory factor (MIF) is a potent proinflammatory mediator that has been shown to potentiate lethal endotoxemia and to play a…”
Get full text

Glucocorticoid resistance in asthma by Barnes, P J, Greening, A P, Crompton, G K

Get more information

Proinflammatory cytokines in acute asthma by Brown, P H, Crompton, G K, Greening, A P

“…Cytokine-mediated interactions between monocytes/macrophages, lymphocytes, and eosinophils may be important in regulation of airway inflammation in asthma…”
Get more information

Pneumocystis carinii in bronchoalveolar lavage fluid and bronchial washings by MATUSIEWICZ, S. P, FERGUSSON, R. J, GREENING, A. P, CROMPTON, G. K, BURNS, S. M

“…Bronchoalveolar lavage fluid and bronchial washings in patients with various clinical diagnoses were examined to see whether Pneumocystis carinii exists as a…”
Get full text